EMILY MCLAIN: Open Payments
NPI 1912396193 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 124 payments from 28 companies in 2025. Trend: 2023 $3,028 · 2024 $2,839 · 2025 $2,414
Food & beverage: $2,414
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $265 |
| BETA BIONICS, INC. | 11 | $246 |
| Lilly USA, LLC | 11 | $218 |
| Xeris Pharmaceuticals, Inc. | 12 | $197 |
| Corcept Therapeutics | 10 | $189 |
| Novo Nordisk Inc | 9 | $154 |
| Madrigal Pharmaceuticals | 6 | $123 |
| Sequel Med Tech, LLC | 5 | $121 |
| Mannkind Corporation | 5 | $104 |
| Amgen Inc. | 6 | $93 |
Products named: FREESTYLE LIBRE 3, iLet Bionic Pancreas, MOUNJARO, Korlym, GVOKE HYPOPEN, REZDIFFRA, TWIIST, AFREZZA.
Industry payments across OK — which companies pay providers there.
